before RFA and 22 been proved RCC. The number of RFA needle treatment were significantly correlated to PADUA score. 13 patients were under local anesthesia, the other were under IVGA by anesthesiologist. Only one patient presented mild pneumothorax after RFA without intervention treatment. Renal function deterioration after procedure did not reveal clinical significance. Tumor recurrence was recognized by CT scan in 3 patients during followup, who repeated RFA treatment without recurrence. Conclusion: For carefully selected patients, RFA represent a less invasive alternative associated with less morbidity and fewer complications and a promising treatment compared with partial nephrectomy. However, the long-term efficacy of these approaches remains to be established. Purpose: Long-term metabolic syndrome develops lower urinary tract symptoms. The pathophysiology mechanism underlying the metabolic syndrome associated with bladder dysfunction is still not clear. The major aim of our study is to elucidate metabolic syndrome-induced bladder dysfunction in association with oxidative stress triggered through mitochondria and endoplasmic reticulum (ER) in a metabolic syndrome einduced bladder overactivity rat model. The other aim of the present study is to elucidate the protective effect of epigallocatechin gallate (EGCG) on metabolic syndrome einduced bladder overactivity. Materials and Methods: Female Sprague-Dawley rats are divided into control group, high fat high sugar (HFHS) diet group, HFHS diet with bilateral ovariectomy (OVX) (HFHS +OVX) group, HFHS diet with bilateral OVX and EGCG treatment (HFHS+OVX+EGCG) group, and HFHS diet with EGCG (HFHS+EGCG) group, respectively. Cystometry (CMG) and micturition frequency/volume studies were recorded for bladder voiding function. The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was performed to evaluate the distribution of apoptotic cells. Western blot was carried out to examine the expressions of interstitial fibrosis markers, muscarinic receptors (M2 and M3), oxidative stress markers, endoplasmic reticulum stress markers (GRP78, CHOP, caspase-12), apoptosis-associated proteins, and the subunits of mitochondrial respiratory complexes. The antioxidant enzymes, including superoxide dismutase and catalase, were investigated by realtime PCR.
Purpose: Long-term metabolic syndrome develops lower urinary tract symptoms. The pathophysiology mechanism underlying the metabolic syndrome associated with bladder dysfunction is still not clear. The major aim of our study is to elucidate metabolic syndrome-induced bladder dysfunction in association with oxidative stress triggered through mitochondria and endoplasmic reticulum (ER) in a metabolic syndrome einduced bladder overactivity rat model. The other aim of the present study is to elucidate the protective effect of epigallocatechin gallate (EGCG) on metabolic syndrome einduced bladder overactivity. Materials and Methods: Female Sprague-Dawley rats are divided into control group, high fat high sugar (HFHS) diet group, HFHS diet with bilateral ovariectomy (OVX) (HFHS +OVX) group, HFHS diet with bilateral OVX and EGCG treatment (HFHS+OVX+EGCG) group, and HFHS diet with EGCG (HFHS+EGCG) group, respectively. Cystometry (CMG) and micturition frequency/volume studies were recorded for bladder voiding function. The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was performed to evaluate the distribution of apoptotic cells. Western blot was carried out to examine the expressions of interstitial fibrosis markers, muscarinic receptors (M2 and M3), oxidative stress markers, endoplasmic reticulum stress markers (GRP78, CHOP, caspase-12), apoptosis-associated proteins, and the subunits of mitochondrial respiratory complexes. The antioxidant enzymes, including superoxide dismutase and catalase, were investigated by realtime PCR. Results: The HFHS diet with OVX treated rats displayed bladder overactivity. Bladder contractility was considerably decreased in HFHS with OVX group in response to electric field, carbachol, and KCl stimulation as compared with those in the control group. Such bladder dysfunction was accompanied by a significant increase in oxidative stress markers, ERassociated oxidative stress proteins, apoptosis-associated proteins, and the subunits of mitochondrial respiratory complexes. Conversely, the mRNA expressions of antioxidant enzymes Mn-SOD, Cu/Zn-SOD and catalase were also decreased after long-term HFHS treatment with/without OVX.
However, EGCG treatment can improve the extent of oxidative stress and lessen bladder hyperactivity. Conclusion: HFHS combined with OVX enhanced the generation of oxidative stress mediated through mitochondria-and ER-dependent pathways, and consequently attributed to bladder apoptosis, whereas EGCG treatment could eliminate these oxidative stress and reverse bladder dysfunctions.
NDP091: FUNCTIONAL BLADDER CAPACITY CORRELATES TO SEVERITY OF SYMPTOMS IN PATIENTS WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME
Hui-Ying Liu, Yao-Chi Chuang. Division of Urology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taiwan Purpose: To investigate the correlation between functional bladder capacity and the pain scale, and clinical symptoms in patients with interstitial cystitis/painful bladder syndrome (IC/PBS). Materials and Methods: A retrospective study of 30 patients with symptoms of IC/PBS were included. Functional bladder capacity was detected according to 3-day voiding diary. Bladder hydrodistention were performed under intravenous sedation or general anesthesia. A self-administered questionnaire containing pain and urgency visual analogue scale (VAS), O'Leary-Sant Symptom and Problem Indexes (including Interstitial Cystitis Symptoms Index (ICSI) and Interstitial Cystitis Problem Index (ICPI)) were obtained. The effects of hydrodistension were evaluated by Global Response Assessment (GRA). A two-sample t test was performed to identify the differences of continuous variables between the two groups with functional bladder capacity of > 350ml and 350ml, and simple logistic regression was applied to assess functional bladder capacity with pain scale, symptom score, age, and bladder capacity in hydrodistention. The p value <0.05 was considered to be statistically significant. Statistical analyses were performed using SPSS 20.0 statistics software (SPSS Inc., Chicago, IL). Results: The baseline character has no significant difference between two groups (functional bladder capacity of > 350ml and 350ml) in age, pain and urgency VAS, ICSI, ICPI, or post-voiding residual urine amount. There is a trend of higher pain scale and symptom score as functional bladder capacity decreased. Furthermore, mean urgency in 3-day voiding diary, bladder capacity on hydrodistention, and GRA showed statistically significant difference between two groups. Conclusion: Functional bladder capacity correlates with pain scale and symptom scores. The group of functional bladder capacity > 350ml has larger bladder capacity in hydrodistention and significantly symptoms improvement after hydrodistension. those (27 patients) with smaller stone (<1cm, group B). By multiple regression, larger ureteral stone, higher shock wave numbers and KV were associated with higher oxidative stress and lower antioxidant capacity immediately after ESWL. Besides, negative correlation was found between oxidative stress and renal function immediately after ESWL.
Conclusion: An increase of MDA and decrease of TOA in blood in all the patients immediately after ESWL, which might induce renal damage. Moreover, the oxidative stress levels in blood was higher and antioxidant capacity was lower in patients who had larger ureteral stone (>1cm), severe hydronephrosis and receive higher shock wave numbers (>4000) and KV (>17). cases whereas bilateral side stones were 20 cases. 6 cases were ureteropelvic junction stones whereas 10 cases had concomitantly bladder stones (a 80 years old male received cystolithotomy for huge bladder stone 4 cm X 3 cm and right URSM + JJ stent concomitantly) and 1 had penile urethral stone whom received cystoscopy lithotripsy simutaneously. 2 cases had incidentally noted of papillary bladder TCC and bladder papilloma whom received biopsy with close surveillance. Average hospitalization was 1-2 days with minimal complication. Foley was keep for 1 day. Average JJ stent was left for 1-2 weeks whereas 1 month for renal pelvic stone. Conclusion: Idiopathic uric acid nephrolithiasis appears to be increasing in prevalence as in our urolithiasis cases. Ultrasound is mostly used for the first line diagnostic tool in detecting nephrolithiasis or obstructive hydronephrosis. While CT scan without enhancement is more sensitive to detect ureter stone especially uric acid stone (radiolucent) without renal toxicity consequences. Further, CT scan is cheap (about NT 3500), fast and convenient. While it has long been known that low urine pH is associated with uric acid stones, alkalinization treatment will provide benefit in mostly cases.
NDP093: THE DIAGNOSIS AND MANAGEMENT OF UROLITHIASIS IN NORTHERN MALAYSIA

